Detalhe da pesquisa
1.
HiJAKing Immunotherapy-Resistant Melanoma for a Cure.
Oncologist
; 28(3): 196-198, 2023 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36640142
2.
Gfi1 controls the formation of effector CD8 T cells during chronic infection and cancer.
bioRxiv
; 2024 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38659890
3.
HIF1α-glycolysis engages activation-induced cell death to drive IFN-γ induction in hypoxic T cells.
Res Sq
; 2024 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38260594
4.
Selective suppression of melanoma lacking IFN-γ pathway by JAK inhibition depends on T cells and host TNF signaling.
Nat Commun
; 13(1): 5013, 2022 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36008408